Sign Up to like & get
recommendations!
0
Published in 2017 at "Yonsei Medical Journal"
DOI: 10.3349/ymj.2017.58.4.778
Abstract: Purpose Peramivir is the first intravenously administered neuramidase inhibitor for immediate delivery of an effective single-dose treatment in patients with influenza. However, limited data are available on intravenous (IV) peramivir treatment compared to oral oseltamivir…
read more here.
Keywords:
peramivir;
treatment;
oral oseltamivir;
meta analysis ... See more keywords